ACA
NEUTRALM&AArcosa, Inc.
This is the 2026-08-20 snapshot — the signals and analysis for ACA as of this single trading day.
View full ACA research hub →Analysis
Arcosa's (ACA) exceptionally low annualized volatility of 2.7% and its 'QUIET_STORM' technical signal are the direct result of its pending $8.5 billion all-cash acquisition by CRH at $150 per share. The stock is currently pinned at $145.40, reflecting a standard merger arbitrage spread ahead of the September 4, 2026, stockholder vote. Furthermore, the current RISK_ON macro regime and exceptionally tight credit spreads (0.81%) provide supreme institutional confidence that the deal's financing is secure. Consequently, the stock is completely ignoring broader geopolitical tensions, acting instead as a high-conviction yield instrument for arbitrageurs.
Fired Signals
Key Takeaways
- Actionable Thesis: ACA is a pure merger arbitrage play, offering a defined upside to the $150 all-cash buyout price by CRH [1.2.8].
- Key Risk: Deal collapse due to unforeseen regulatory hurdles or a shareholder vote failure on September 4, which would immediately reprice the stock to pre-deal levels.
- What to Watch: Monitor the September 4 Special Meeting of Stockholders and ensure credit spreads remain tight to guarantee deal financing.